Immuno-Oncology

The rapidly changing field of immuno-oncology has begun to show great potential to revolutionize cancer treatment. To support the advancement of immuno-oncology diagnostics and treatment in the laboratory ASCP is committed to developing education designed to: enhance general knowledge and skills related to immuno-oncology among pathologists and laboratory professionals; support the implementation and dissemination of best practices in immuno-oncology testing, treatment options, and communication in multidisciplinary teams to improve quality of care; and increase awareness of new developments in the rapidly changing field of immuno-oncology.

Educational Activities
Activities

Introduction to Immuno-oncology (IO) 

Breakthroughs in immuno-oncology are showing great potential to revolutionize cancer treatment, but keeping up-to-date with new testing protocols, diagnoses, and therapeutic treatments is challenging for many pathologists and laboratory professionals. The courses below will provide you with an introduction to IO and the basic concepts.

An Overview of Immuno-Oncology

Funded by an independent educational grant from Bristol-Myers Squibb.

Learn More/Register Now

Update on Immuno-Oncology Biomarkers

Funded by an independent educational grant from Bristol-Myers Squibb.

Register Now View on YouTube Download Handout

 

Basic Concepts in Predictive Biomarkers for Immuno-Oncology
Funded by an independent educational grant from Pfizer/Merck KGaA.

Learn More/Register Now

Understanding the Importance of Mismatch Repair Deficiency and Microsatellite Instability in Pathology
Funded by an independent educational grant from Pfizer/Merck KGaA.

Learn More/Register Now

Genomics and NGS

In the rapidly expanding field of immuno-oncology (IO), checkpoint inhibitors are gaining new or expanded approvals with such increasing frequency that it’s hard for community-based oncologists and pathologists to keep up.  The following courses will expand on your knowledge of how IO and Genomics work together.

Tumor Biology 101: Detecting Genomic Targets and Mutation Patterns

Funded by an independent educational grant from Pfizer/Merck KGaA.

Learn More/Register Now

Immuno-Oncology: Next-Generation Sequencing and the New Biomarker Landscape
Funded by an independent educational grant from Bristol-Myers Squibb.

Learn More/Register Now

Immune-Related Adverse Events

The rapid rate of breakthroughs in immuno-oncology has outpaced continuing education in medicine, lleaving pathologists and laboratory teams with a gap in optimal awareness about the core science of pan-tumor immuno-oncology checkpoints, biomarkers, pathways, and therapeutics. A growing body of research has documented the impact of advances in immunotherapy treatments on pathology diagnostics, but new developments have outpaced the laboratory team’s skills in recognizing side effects, especially immune-related adverse events (irAEs), induced by these novel therapies and checkpoint inhibitors. Learn more about these effects with the course below.  

Immune-Related Adverse Events Secondary to Checkpoint-Inhibitor Therapy

Funded by an independent educational grant from Bristol-Myers Squibb.

Learn More/Register Now

Implementing IO in Community Settings

Immuno-oncology (IO) is showing significant promise in treating cancer patients where other approaches have failed. As breakthroughs in IO continue to revolutionize cancer treatment, pathologists and laboratory professionals—particularly those who practice in smaller, community-based settings — are challenged with keeping informed about, and the implementation of, new testing protocols, diagnosis, and therapeutic treatments. The following courses below help address the concerns of community based practice.  

Advancing the Application of Immuno-Oncology to Improve Patient Care

Funded by an independent educational grant from Pfizer/Merck KGaA.

Learn More/Register NowView on YouTube

Overcoming Common Barriers Around the Application of Immuno-Oncology in Community Settings

Funded by an independent educational grant from Pfizer/Merck KGaA.

Learn More/Register NowView on YouTube

Implementing Immuno-Oncology Education in a Community Cancer Center

Funded by an independent educational grant from Bristol-Myers Squibb.

Learn More/Register Now

Hot Topics in IO

The following courses are a quarterly series of 30-minute on-demand webcasts containing up-to-the-minute information on various therapeutic agents, disease states, and thresholds that impact immuno-oncology diagnostics in solid tumors and hematologic malignancies. 

Funded by an independent educational grant from AstraZeneca.

ASCP Scientific Update 1: Molecular Marker Testing Recommendations for Lung Cancer Treatment

Register Now View on YouTube Read the Highlights

ASCP Scientific Update 2: An Introduction to CAR T-Cell Therapy

Register Now View on YouTubeRead the Highlights

ASCP Scientific Update 3: Tumor Mutational Burden

Register NowView on YouTubeRead the Highlights

ASCP Scientific Update 4: Liquid Biopsies: Current Limitations and Potential Applications

Register NowView on YouTube Read the Highlights

 

ASCP Scientific Update 2018 Quarter 1 and 2: Package for Laboratory Professionals

Disclaimer: Laboratory Professionals in Florida must take this package to receive CMLE credit. This package is CMLE credit only.

Register Now

 

ASCP Scientific Update 2018 Quarter 3 and 4: Package for Laboratory Professionals

Disclaimer: Laboratory Professionals in Florida must take this package to receive CMLE credit. This package is CMLE credit only.

Register Now